Aim Immunotech logo

Aim Immunotech Share Price Today

(NASDAQ: AIM)

Aim Immunotech share price is $0.13 & ₹11.31 as on 6 Mar 2025, 2.30 'hrs' IST

$0.13

0.01

(6.56%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Aim Immunotech share price in Dollar and Rupees. Guide to invest in Aim Immunotech stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Aim Immunotech, along with analyst recommendations, forecasts, and comprehensive financials.

Aim Immunotech share price movements

  • Today's Low: $0.12
    Today's High: $0.14

    Day's Volatility :13.04%

  • 52 Weeks Low: $0.11
    52 Weeks High: $0.62

    52 Weeks Volatility :82.18%

Aim Immunotech (AIM) Returns

PeriodAim Immunotech IncIndex (Russel 2000)
3 Months
-35.88%
0.0%
6 Months
-60.28%
0.0%
1 Year
-66.24%
0.0%
3 Years
-80.66%
-11.6%

Aim Immunotech (AIM) Key Statistics

in dollars & INR

Previous Close
$0.1234
Open
$0.1236
Today's High
$0.138
Today's Low
$0.12
Market Capitalization
$8.5M
Today's Volume
$1.2M
52 Week High
$0.62
52 Week Low
$0.1105
Revenue TTM
$190.0K
EBITDA
$-27.7M
Earnings Per Share (EPS)
$-0.48
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-187.58%

How to invest in Aim Immunotech Stock (AIM) from India?

It is very easy for Indian residents to invest directly in Aim Immunotech from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aim Immunotech stock in both Indian Rupees (INR) and US Dollars (USD). Search for Aim Immunotech or AIM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aim Immunotech or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aim Immunotech shares which would translate to 6.690 fractional shares of Aim Immunotech as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Aim Immunotech, in just a few clicks!

Returns in Aim Immunotech (AIM) for Indian investors in Rupees

The Aim Immunotech stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Aim Immunotech investment value today

Current value as on today

₹38,282

Returns

₹61,718

(-61.72%)

Returns from Aim Immunotech Stock

₹66,667 (-66.67%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Aim Immunotech (AIM)

-36%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Aim Immunotech Stock from India on INDmoney has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Aim Immunotech

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Aim Immunotech(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Aim Immunotech Stock (AIM)

What analysts predicted

Upside of 2015.38%

Target:

$2.75

Current:

$0.13

Insights on Aim Immunotech Stock (Ticker Symbol: AIM)

  • Price Movement

    In the last 6 months, AIM stock has moved down by -59.9%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 50.0K → 35.0K (in $), with an average decrease of 30.0% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -1.83M → -3.7M (in $), with an average decrease of 101.5% per quarter
  • AIM vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 132.7%
  • AIM vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 132.8%
  • Price to Sales

    ForAIM every $1 of sales, investors are willing to pay $32.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Aim Immunotech Technicals Summary

Sell

Neutral

Buy

Aim Immunotech is currently in a neutral trading position according to technical analysis indicators.

Aim Immunotech (AIM) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Aim Immunotech Inc logo
-26.99%
-60.28%
-66.24%
-80.66%
-97.84%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Aim Immunotech Inc logo
NA
NA
NA
-0.3
-1.88
-0.84
NA
0.05
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Aim Immunotech Inc logo
Buy
$8.5M
-97.84%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Aim Immunotech

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat human papilloma viruses, and genital warts, a sexually transmitted disease. AIM ImmunoTech Inc. has agreements with Amarex Clinical Research LLC; University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente; Jubilant HollisterStier; Sterling Pharma Solutions; Erasmus University Medical Center Rotterdam; Azenova, LLC; and Alcami Corporation. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.
Organization
Aim Immunotech
Employees
26
CEO
Mr. Thomas K. Equels Esq., J.D., M.S.
Industry
Health Technology

Management People of Aim Immunotech

NameTitle
Mr. Thomas K. Equels Esq., J.D., M.S.
Executive Vice Chairman, CEO & President
Mr. Robert Dickey IV, M.B.A.
Chief Financial Officer
Mr. Peter W. Rodino III, Esq., J.D.
COO, Executive Director of Governmental Relations, General Counsel & Secretary
Dr. Christopher McAleer Ph.D.
Scientific Officer
Ann Marie E. Coverly
Director of Administration & Human Resources and Deputy Investor Relations Coordinator
Dr. Ralph Christopher Cavalli Ph.D.
Vice President of QC & Manufacturing

Important FAQs about investing in AIM Stock from India :

What is Aim Immunotech share price today?

Aim Immunotech share price today stands at $0.13, Open: $0.12 ; Previous Close: $0.12 ; High: $0.14 ; Low: $0.12 ; 52 Week High: $0.62 ; 52 Week Low: $0.11.

The stock opens at $0.12, after a previous close of $0.12. The stock reached a daily high of $0.14 and a low of $0.12, with a 52-week high of $0.62 and a 52-week low of $0.11.

Can Indians buy Aim Immunotech shares?

Yes, Indians can invest in the Aim Immunotech (AIM) from India.

With INDmoney, you can buy Aim Immunotech at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Aim Immunotech at zero transaction cost.

How can I buy Aim Immunotech shares from India?

It is very easy to buy Aim Immunotech from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aim Immunotech (AIM) be purchased?

Yes, you can buy fractional shares of Aim Immunotech with INDmoney app.

What are the documents required to start investing in Aim Immunotech stocks?

To start investing in Aim Immunotech, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Aim Immunotech Stock (AIM)?

Today’s highest price of Aim Immunotech (AIM) is $0.14.

Today’s lowest price of Aim Immunotech (AIM) is $0.12.

What is today's market capitalisation of Aim Immunotech?

Today's market capitalisation of Aim Immunotech AIM is 8.5M

What is the 52 Week High and Low Range of Aim Immunotech Stock (AIM)?

  • 52 Week High

    $0.62

  • 52 Week Low

    $0.11

What are the historical returns of Aim Immunotech (AIM)?

  • 1 Month Returns

    -26.99%

  • 3 Months Returns

    -60.28%

  • 1 Year Returns

    -66.24%

  • 5 Years Returns

    -97.84%

Who is the Chief Executive Officer (CEO) of Aim Immunotech ?

Mr. Thomas K. Equels Esq., J.D., M.S. is the current Chief Executive Officer (CEO) of Aim Immunotech.